Skip to main content
The driveway to the Kay Jewelers Pavilion on our Akron Campus will be closed for 2-4 weeks beginning Oct. 10. Click HERE for details.
Go to homepage

Oxybutynin for Neurogenic Bladder

Safety and effectiveness of oxybutynin in children (6-16 years) with neurogenic bladder

Who May Qualify?:

Patients 6-16 years old with neurogenic detrusor overactivity

Who Does Not Qualify:

Patients who are pregnant, involved in other investigational studies or have certain medical conditions

Interested in participating?
We are currently recruiting
Full IRB Study Title:
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study Evaluating the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride Topical Gel for the Treatment of Detrusor Overactivity Associated with a Neurological Condition in Pediatric Subjects
IRB Study ID:
110208
If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

Lead Investigator
Daniel McMahon MD

Director, Pediatric Urology; Pediatric Urologist
Pediatric Urology